These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 9209733)
1. In vivo proton magnetic resonance spectroscopy of Alzheimer's disease in the parietal and temporal lobes. Frederick BB; Satlin A; Yurgelun-Todd DA; Renshaw PF Biol Psychiatry; 1997 Jul; 42(2):147-50. PubMed ID: 9209733 [No Abstract] [Full Text] [Related]
2. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging. Zhu X; Schuff N; Kornak J; Soher B; Yaffe K; Kramer JH; Ezekiel F; Miller BL; Jagust WJ; Weiner MW Alzheimer Dis Assoc Disord; 2006; 20(2):77-85. PubMed ID: 16772742 [TBL] [Abstract][Full Text] [Related]
3. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease. Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758 [TBL] [Abstract][Full Text] [Related]
4. Contribution of 1H spectroscopy to a brief cognitive-functional test battery for the diagnosis of mild Alzheimer's disease. Silveira de Souza A; de Oliveira-Souza R; Moll J; Tovar-Moll F; Andreiuolo PA; Bottino CM Dement Geriatr Cogn Disord; 2011; 32(5):351-61. PubMed ID: 22311276 [TBL] [Abstract][Full Text] [Related]
5. Mapping of temporal and parietal cortex in progressive nonfluent aphasia and Alzheimer's disease using chemical shift imaging, voxel-based morphometry and positron emission tomography. Zahn R; Buechert M; Overmans J; Talazko J; Specht K; Ko CW; Thiel T; Kaufmann R; Dykierek P; Juengling F; Hüll M Psychiatry Res; 2005 Nov; 140(2):115-31. PubMed ID: 16253483 [TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance spectroscopic study of Alzheimer's disease and frontotemporal dementia/Pick complex. Mihara M; Hattori N; Abe K; Sakoda S; Sawada T Neuroreport; 2006 Mar; 17(4):413-6. PubMed ID: 16514368 [TBL] [Abstract][Full Text] [Related]
7. Proton magnetic resonance spectroscopy in frontotemporal dementia. Coulthard E; Firbank M; English P; Welch J; Birchall D; O'Brien J; Griffiths TD J Neurol; 2006 Jul; 253(7):861-8. PubMed ID: 16845570 [TBL] [Abstract][Full Text] [Related]
8. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Ernst T; Chang L; Melchor R; Mehringer CM Radiology; 1997 Jun; 203(3):829-36. PubMed ID: 9169712 [TBL] [Abstract][Full Text] [Related]
9. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. Modrego PJ; Fayed N; Pina MA Am J Psychiatry; 2005 Apr; 162(4):667-75. PubMed ID: 15800137 [TBL] [Abstract][Full Text] [Related]
10. Progressive biparietal atrophy: an atypical presentation of Alzheimer's disease. Ross SJ; Graham N; Stuart-Green L; Prins M; Xuereb J; Patterson K; Hodges JR J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):388-95. PubMed ID: 8890778 [TBL] [Abstract][Full Text] [Related]
11. MRS in relation to hippocampal volume in the oldest old. Spencer DC; Zitzelberger T; Spielman D; Kaye J Neurology; 2003 Apr; 60(7):1194-6. PubMed ID: 12682335 [TBL] [Abstract][Full Text] [Related]
12. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Schuff N; Capizzano AA; Du AT; Amend DL; O'Neill J; Norman D; Kramer J; Jagust W; Miller B; Wolkowitz OM; Yaffe K; Weiner MW Neurology; 2002 Mar; 58(6):928-35. PubMed ID: 11914410 [TBL] [Abstract][Full Text] [Related]
13. A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease. Firbank MJ; Harrison RM; O'Brien JT Dement Geriatr Cogn Disord; 2002; 14(2):64-76. PubMed ID: 12145453 [TBL] [Abstract][Full Text] [Related]
14. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease. Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028 [TBL] [Abstract][Full Text] [Related]
15. 1H-proton magnetic resonance spectroscopy differentiates dementia with Lewy bodies from Alzheimer's disease. Zhong X; Shi H; Shen Z; Hou L; Luo X; Chen X; Liu S; Zhang Y; Zheng D; Tan Y; Huang G; Fang Y; Zhang H; Mu N; Chen J; Wu R; Ning Y J Alzheimers Dis; 2014; 40(4):953-66. PubMed ID: 24531156 [TBL] [Abstract][Full Text] [Related]
16. Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment. Bokde AL; Lopez-Bayo P; Meindl T; Pechler S; Born C; Faltraco F; Teipel SJ; Möller HJ; Hampel H Brain; 2006 May; 129(Pt 5):1113-24. PubMed ID: 16520329 [TBL] [Abstract][Full Text] [Related]
17. Focal temporoparietal slow activity in Alzheimer's disease revealed by magnetoencephalography. Fernández A; Maestú F; Amo C; Gil P; Fehr T; Wienbruch C; Rockstroh B; Elbert T; Ortiz T Biol Psychiatry; 2002 Oct; 52(7):764-70. PubMed ID: 12372668 [TBL] [Abstract][Full Text] [Related]
18. An in vitro 1H nuclear magnetic resonance study of the temporoparietal cortex of Alzheimer brains. Mohanakrishnan P; Fowler AH; Vonsattel JP; Husain MM; Jolles PR; Liem P; Komoroski RA Exp Brain Res; 1995; 102(3):503-10. PubMed ID: 7737396 [TBL] [Abstract][Full Text] [Related]
19. In vivo short echo time 1H-magnetic resonance spectroscopic imaging (MRSI) of the temporal lobes. McLean MA; Woermann FG; Simister RJ; Barker GJ; Duncan JS Neuroimage; 2001 Aug; 14(2):501-9. PubMed ID: 11467922 [TBL] [Abstract][Full Text] [Related]
20. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study. Waldman AD; Rai GS Neuroradiology; 2003 Aug; 45(8):507-12. PubMed ID: 12879326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]